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Prevalence and risk factors for dyslipidemia
among adults in rural and urban China:
findings from the China National Stroke
Screening and prevention project (CNSSPP)
Sampson Opoku1, Yong Gan1, Wenning Fu1, Dajie Chen1, Emmanuel Addo-Yobo2, Diana Trofimovitch3, Wei Yue4,
Feng Yan5, Zhihong Wang6 and Zuxun Lu1*

Abstract
Background: Dyslipidemia is a modifiable risk factor for cardiovascular disease (CVD). We investigated the
prevalence and associated risk factors of dyslipidemia- raised total cholesterol (TC), raised triglycerides (TG), raised
low-density lipoprotein (LDL-C), low high-density lipoprotein (HDL-C), and raised non-high-density lipoprotein (nonHDL-C) in rural and urban China.
Methods: We analyzed data from 136,945 participants aged 40–100 years of the CNSSPP project for 2014.
Dyslipidemia was defined by the NCEP-ATP III and the 2016 Chinese guidelines for the management of
dyslipidemia in adults. Complete data on demographic, metabolic and lifestyle characteristics were used. Chi-square
tests and multivariable logistic regression were used to obtain age- and sex-adjusted prevalence and risk factors for
dyslipidemia among participants.
Results: A total of 53.1% participants lived in rural areas. The prevalence of dyslipidemia was similar among rural
and urban participants (43.2% vs. 43.3%). Regarding the components of dyslipidemia: urban compared with rural
participants had a higher prevalence of low HDL-C (20.8% vs. 19.2%), whereas the prevalence of raised LDL-C (7.8%
vs. 8.3%), raised TC (10.9% vs.11.8%) and raised non-HDL-C (10.0% vs. 10.9%) were lower in urban residents, (all p <
0.001). Women were more likely to have raised TC than men (adjusted OR [AOR] =1.83, 95% confidence interval [CI]:
1.75–1.91), raised LDL-C (AOR = 1.55, 95% CI: 1.47–1.63) and high non-HDL-C (AOR = 1.52 95% CI: 1.45–1.59) (all p <
0.001). Compared with rural, urban participants had higher odds of dyslipidemia: low HDL-C (AOR = 1.04, 95% CI:
1.01–1.07), and raised TG (AOR = 1.06, 95% CI: 1.04–1.09). Hypertension and current drinker were less likely to get
low HDL-C with AOR 0.93 (95% CI: 0.90–0.96) and AOR 0.73 (95% CI: 0.70–75), respectively. Overweight, obesity,
central obesity and diabetes had higher odds of all dyslipidemias (p < 0.001).
Conclusions: Low HDL-C was higher in urban areas, whereas the remaining dyslipidemia types were more common
in rural areas. Dyslipidemia was more common in women in both areas of residence. Overweight, obesity, central
obesity and diabetes were associated with dyslipidemias. The need to intensify intervention programs to manage
dyslipidemia and risk factors should be prioritized.
Keywords: Dyslipidemia, Rural, Urban, Risk factors, Prevalence
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Background
Cardiovascular disease (CVD) constitutes the greatest
cause of morbidity and mortality with a high incidence and prevalence in countries of all economic
groups [1]. In China, CVD is a leading contributor to
morbidity, mortality and disability-adjusted life-years
(DALYs) [2]. In addition, an increased prevalence of
CVD implies high costs to individuals and the state
[3]. Therefore, managing the risk factors for CVD is
necessary for the control of cardiovascular disease
epidemic in China [4]. Prior studies in China and
other countries have linked CVD events and burden
to factors like poor knowledge of risk factors, changes
in lifestyle due to rapid urbanization, epidemiologic
and economic transitions [5–8].
Dyslipidemia is a major cardiovascular risk factor; it is
a group of metabolic derangements characterized by any
or a combination of the following: raised low-density
lipoprotein cholesterol (LDL-C), raised total cholesterol
(TC), raised triglycerides (TG) and low high-density
lipoprotein cholesterol (HDL-C) [9].
Lipid abnormalities are associated with an increased
risk of CV events including coronary heart disease
(CHD), thereby serving as contributors to this process.
The impact of cholesterol abnormalities on CHD risk is
increased if other risk factors such as obesity are simultaneously present. Adverse lipid profiles have been found
to be a risk factor for the first coronary event. It appears
to be highly predictive of recurrent events, too [10–12].
Therefore, the prevention and control of dyslipidemia
especially in adult populations are important to help reduce CV events.
China has experienced dramatic socio-economic
transition in the past decades with great rural-urban
migration [13, 14]. Earlier studies in parts of China
have shown trends towards increase in the prevalence
of dyslipidemia in urban areas [6, 15]. However, limited data are available on the nationwide distribution
of dyslipidemia prevalence based on rural vs. urban
living. It is possible that those who live in rural areas
may have a less healthy lifestyle and therefore could
have higher prevalence [16]. Therefore, we aimed to
determine the prevalence of dyslipidemia and risk factors among adults aged ≥40 living in rural and urban
China.
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described elsewhere [17]. Briefly, it was a crosssectional survey involving Chinese adults aged 40 years
or older. Employing a multistage cluster probability
sampling strategy, 200 project areas were first selected
in proportion to the local population size and the total
number of counties. Subsequently, an urban community and a rural village were selected from each project
area as primary sampling units according to geographical locations and suggestions from local hospitals. The
cluster sampling method was used in every primary
sampling unit and all residents aged 40 years or above
were interviewed during the primary screening sections.
Measurement of indicators

A questionnaire was used to obtain baseline information
from participants by trained investigators. It contained
demographic characteristics (such as age, sex, and ethnicity), geographical zones (such as north and south, and
stroke belt), medical history (such as CHD, dyslipidemia,
stroke, hypertension and diabetes), and lifestyle activities
(such as tobacco smoking, alcohol use and physical activity). The baseline data were further categorized by
other parameters. Age was recorded as subjects’ current
age and grouped as follows: ‘40–49′, ‘50–59′, ‘60–69′,
and ‘70’ years and above [15]. Smoking status was classified into ‘non-smoker’ and ‘current smoker’ (current
smoker is one who smokes at least one cigarette per
day). Alcohol use status was categorized into ‘current
drinker’ and ‘non-drinker’ (current drinker is one who
drinks alcoholic beverages ≥1 per week for more than
half a year). Physical activity was classified into ‘yes’ and
‘no’ (yes refers to physical activity of ≥3 times per week
for at least 30 min each episode, or engaged in heavy
physical work) by self-reported information.
Nationality was grouped into two: Han and other Ethnicities. Socio-economic regions were classified as high,
middle, and low-income levels according to the per
capita disposable income household’s thresholds in 2014
[18]. High-income regions included Beijing, Fujian,
Guangdong, Jiangsu, Liaoning, Inner Mongolia, Shanghai, Shandong, Tianjin and Zhejiang. Middle-income
regions were Anhui, Chongqing, Hainan, Hebei, Heilongjiang, Hubei, Hunan, Jilin, Jiangxi and Shanxi. And
low-income regions included Henan, Guangxi, Sichuan,
Guizhou, Yunnan, Shaanxi, Gansu, Qinghai, Ningxia,
and Xinjiang.

Methods
Study population

Definitions

This study utilized the 2014 data from the China National Stroke Screening and Prevention Project
(CNSSPP). It was a survey conducted by the National
Project Office for Stroke Prevention and Control that
consists of a representative sample of the Chinese
adult’s population. Details of this survey have been

An urban area was defined with a 12-component studyspecific urbanization index. This criterion had been previously validated to capture the degree of urbanization
in the study communities (reliability across study waves
[Cronbach’s Alpha]: 0.85–0.89; validity [correlation with
official classification]; 0.75–0.78) [19]. The following 12
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components were included in the development of the
urbanization index: (1) population density, (2) housing,
(3) traditional market, (4) sanitation, (5) transportation
and infrastructure, (6) modern markets, (7) communications (e.g. TV and cinema), (8) types of economic activity (e.g. electricity and flush toilet), (9) education, (10)
diversity (i.e. greater diversity in community education
level, and greater variation in community income level),
(11) health infrastructure, and (12) social services such
as the provision of preschool for children under 3 years
old, availability of commercial medical insurance, free
medical insurance, and/or insurance for women and
children. The scale has a range of 0–120, the higher the
score, the more the urban characteristics across these
twelve multiple domains.
Geographically, we classified all participants into two
zones: 1. the northern and southern zones according to
the Huai River–Qin Mountains Line. The Northern zone
included: Heilongjiang, Jilin, Liaoning, Inner Mongolia,
Beijing, Tianjing, Hebei, Henan, Anhui, Shandong,
Shanxi, Shaanxi, Gansu, Ningxia, Qinghai and Xinjiang.
The southern part included: Jiangsu, Zhejiang, Shanghai,
Chongqing, Sichuan, Fujian, Jiangxi, Hubei, Hunan, Guizhou, Guangzhou, Guangxi, Hainan and Yunnan [20]. 2.
The stroke belt. The stroke belt was defined based on a
region containing provinces that met the following two
(2) criteria for a region of high stroke incidence: (1) the
province was ranked in the top one third of provinces
for stroke incidence (i.e., met the above criteria for high
stroke incidence) and (2) more than one third (> 33.3%)
of the prefectural regions within the province were
ranked in the top two sevenths of prefectural regions for
stroke incidence (i.e. met the above criteria for high
stroke incidence) [21].
A history of CHD, dyslipidemia and stroke was defined as self-report of any previous diagnosis of CHD,
dyslipidemia and stroke by a healthcare professional
or currently undergoing treatment. Hypertension was
diagnosed if the subject had a history of hypertension,
or a systolic blood pressure (SBP) ≥ 140 mmHg, or a
diastolic blood pressure ≥ 90 mmHg, or currently taking antihypertensive medications. Diabetes mellitus
was diagnosed if the subject had a history of diabetes
mellitus, or currently undergoing treatment with insulin or oral hypoglycemic agents, or the fasting blood
glucose (FBG) level was ≥7.0 mmol/L.
Physical examination

Body weight and height were measured and then body
mass index (BMI) was calculated as body weight (kg) divided by the square of height (m2) based on the Criteria
of the Ministry of Health, China [22]. Individuals were
categorized into four groups: BMI < 18.5 kg/m2 (underweight), ≥ 18.5 kg/m2 and < 24 kg/m2 (normal weight), ≥
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24 kg/m2 and < 28 kg/m2 (overweight), and ≥ 28 kg/m2
(obesity). Waist circumference (WC) was measured at
the midpoint between the iliac crest and the lower rib.
Men with waist circumference ≥ 90 cm or women with
waist circumference ≥ 85 cm were defined as central
obesity. Blood pressure of participants was measured
after a 20-min seated rest and the mean of three measurements was used for this study.
Biochemical measurements

A standardized protocol was adopted for blood collection and used at all research centers. Only laboratories
that could perform all the biochemical analyses of the
study with strict quality assurance to receive and manage
the collection of samples were used. This allowed for
measures to be standardized and results to be made uniform. All laboratories received instructions on the protocol to be followed including labelling of kits for blood
collection for each adult. Blood samples were obtained
from subjects in the morning after fasting for at least 8
h, and were examined for FBG, TC, TG, LDL-C and
HDL-C according to standard protocols.
Lipid abnormalities were classified according to the
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults final
report (NCEP-ATP III) [23], these classifications were
same as the criteria of the 2016 Chinese guidelines for
the management of dyslipidemia in adults [10]. Borderline high TC level: ≥ 5.22 and < 6.22 mmol/L, high TC
level: ≥ 6.22 mmol/L, borderline high LDL-C: ≥ 3.44
and < 4.1 mmol/L, high LDL-C: ≥ 4.14 mmol/L, low
HDL-C: < 1.04 mmol/L, borderline high TG: ≥ 1.7 and <
2.26 mmol/L, and elevated TG: ≥ 2.26 mmol/L. NonHDL-C was calculated as TC minus HDL-C. Borderline
high non-HDL-C was defined as ≥4.1 and < 4.9 mmol/L,
and high non-HDL-C was defined as ≥4.9 mmol/L [24].
Statistical analysis

Demographic, metabolic and lifestyle characteristics of
participants by residence (rural versus urban) were
expressed using descriptive statistics. The normality of
the continuous variables was assessed, and variables with
a skewed distribution were reported with medians and
interquartile ranges (IQRs), and the chi- square test was
used for the categorical variables. The prevalence and
95% confidence interval (95%CI) for the overall and
components of dyslipidemia by sex, age group and area
of residence were calculated according to the 2010
population census age and sex distribution of China.
Multivariable logistic regression model was used to
analyse the risk factors. In the multivariable analysis,
participants in the socio-economic regions were compared with low-income region and normal, underweight,
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overweight and obese were compared to normal weight
participants. Statistical significance was accepted at the
5% level (p < 0.05). All statistical analyses were performed using SPSS 19.0 (SPSS Inc., Chicago, Ill). Furthermore, processing of graphs and tables was done
using MS Excel 2013.

Results
Population description

A total of 726,451 Chinese adults were recorded in the
2014/2015 CNSSPP database. This study focused on
180,000 subjects randomly selected from all provinces
and municipalities in china. These people were selected
for further assessment for stroke risk factors including
high blood pressure, abnormal serum lipids and physical
examinations [25]. Our analysis was based on the 136,
945 (19%) weighted subjects between 40 and 100 years,
with complete demographic, metabolic and lifestyle data.
More than half of the respondents were from rural
areas 53.1% (n = 72,712). Most of the subjects from both
rural and urban settings were Hans (96.7%). The ageand sex- specific median (IQR) of participants in rural
and urban areas were 55.0 (49.0–62.0) and 56 (50.0–
63.0), respectively. Urban areas recorded more subjects
with history of CHD, dyslipidemia, stroke and come
from the stroke belt zone.
The largest proportion of respondents were between
the ages of 50 to 59 years: 41.8% (n = 30,366) from rural
areas, and 42.8% (n = 27,494) from urban areas. Compared with urban participants, rural ones were more
likely to have hypertension, 63.5% (n = 46,155) vs. 61.2%
(n = 39,280); smoke, 35.3% (n = 25,677) vs. 29.9% (n =
19,174); and be from low and middle- income regions,
(28.0% [n = 20,395]) vs. (18.5% [n = 11,909]), and (32.8%
[n = 23,853] vs. (26.6% [n = 17,097]); p value from χ2 <
0.001). They were also more likely to have higher median lipid values. For example, 4.92 [4.22–5.64]) vs. 4.88
[4.23–5.58]) for TC. Urban compared to rural residents
were more likely to be obese, physically inactive and to
have diabetes (p value from χ2 < 0.001) (Table 1).
The serum lipid concentrations of the study population by area of residence.
Table 2 summarizes the percentages (with 95% confidence intervals) of serum lipid concentrations of the
study participants according to the area of residence.
The overall adjusted prevalence of participants with
borderline-high TC was 28.0% (95% CI 27.8–28.2); high
TC: 11.3% (95% CI 11.2–11.5); borderline-high LDL-C:
18.4% (95% CI 18.2–18.6); and high LDL-C: 8.1% (95%
CI 7.9–8.2). Rural participants were more likely to have
high LDL-C 8.3% (95% CI 8.1–8.5), than their urban
counterparts 7.8% (95% CI 7.5–8.0). Urban versus rural
residents were more likely to get low HDL-C levels
20.8% (95% CI 20.5–21.1) vs. 19.2 (95% CI 18.9–19.5).
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Prevalence of dyslipidemia in rural and urban areas

The age- and sex- standardized prevalence of dyslipidemia
was 43%. The prevalence of dyslipidemia was similar
among rural and urban participants (43.2% vs. 43.3%),
(figure not shown). As presented in Fig. 1, compared with
men, women had higher prevalence of dyslipidemia in
both areas of residence: (rural: 52.0% vs. 48.0%, urban:
54.0% vs. 46.0%; p for χ2 < 0.001). Regarding the five components of dyslipidemia, low HDL-C recorded higher
prevalence in urban as compared to rural participants
(20.8% vs. 19.2%), whereas raised LDL-C had higher
prevalence among rural compared to urban populations
(8.3% vs. 7.8%; (p value from χ2 < 0.001). Raised TC and
raised non-HDL-C also had higher prevalence in rural
compared with urban subjects (11.8% vs.10.9 and 10.9%
vs. 10.0%; p for χ2 < 0.001), respectively. Elevated TG
prevalence among rural and urban adults was comparable
(22.4% vs. 22.5%).
Regarding the prevalence of dyslipidemia stratified by
sex and age groups, significant differences were observed. Men below age 50 had a higher prevalence of
dyslipidemia (33%) than women (22%). The peak prevalence of dyslipidemia in both sexes converged at aged
50–59 years. Afterwards, prevalence declined simultaneously in both sexes, with women recording higher
values than men (p < 0.05) (Fig. 2).
Fig. 3 shows significant differences in dyslipidemia
components according to sex in both rural and urban
settings. All lipid abnormalities were significantly higher
among women than among men in rural settings (p for
χ2 < 0.001) except low HDL-C. Similarly, urban women
had higher levels for raised TC, raised LDL-C and raised
non-HDL-C (p for χ2 < 0.001). While, low HDL-C and
raised TG levels were higher among urban men compared with women (26.2% vs. 16.5 and 23.8% vs. 21.1%;
p for χ2 < 0.001), respectively.
Figure 4 presents the prevalence of the five components of dyslipidemia according to sex and age groups.
Similar prevalence patterns were observed among all the
components. The patterns increased and decreased with
ageing, and were significantly different between men and
women (p value from χ2 < 0.001). The prevalence peaked
at aged 50–59 years and declined afterwards. Below age
50, men were more likely than women to have dyslipidemia, whereas after age 59, men showed lower risk of
dyslipidemia than women.

Risk factors associated with dyslipidemia

Table 3 describes the age- and sex- adjusted prevalence
of dyslipidemia stratified by CVD risk factors. Men versus women had higher raised TC, low HDL-C and raised
TG values (14% vs. 9, 24% vs. 16 and 23% vs. 22%), respectively. A higher prevalence of dyslipidemia was
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Table 1 Demographic, metabolic and lifestyle characteristics of rural and urban 40–100 year-old Chinese adults
Rural (N = 72,712)

Urban (N = 64,233)

Total (N = 13,6945)

No. (%)

No. (%)

No. (%)

Median (IQR)

55.0 (49.0–62.0)

56.0 (50.0–63.0)

55.0 (49.0–63.0)

40–49

20,129 (27.7)

15,922 (24.8)

36,051 (26.3)

50–59

30,366 (41.8)

27,494 (42.8)

57,860 (42.3)

60–69

13,923 (19.1)

12,560 (19.6)

26,483 (19.3)

70 and above

8294 (11.4)

8257 (12.8)

16,552 (12.1)

Men

37,728 (51.9)

32,835 (51.1)

70,563 (51.5)

Women

34,984 (48.1)

31,398 (48.9)

66,382 (48.5)

Yes

65,704 (90.4)

58,702 (91.4)

12,4406 (90.8)

No

7008 (9.6)

5531 (8.6)

12,539 (9.2)

Yes

44,834 (61.8)

40,346 (64.2)

85,180 (62.9)

No

27,722 (38.2)

22,501 (35.8)

50,223 (37.1)

Yes

56,563 (77.8)

51,846 (80.7)

10,8409 (79.2)

No

16,150 (22.2)

12,387 (19.3)

28,537 (20.8)

b

39,102 (53.8)

37,093 (57.7)

76,195 (55.6)

South

33,611 (46.2)

27,140 (42.3)

60,751 (44.4)

c

11,960 (16.4)

11,689 (18.2)

23,649 (17.3)

Non-stroke Belt

60,753 (83.6)

52,544 (81.8)

11,3297(82.7)

20,395 (28.0)

11,909 (18.5)

32,304 (23.6)

Age

Sex

History of CHD

History of Dyslipidemia

History of Stroke

Geographical Regions
North

Stroke Belt

Socio- economic region
Low- income
Middle- income

23,853 (32.8)

17,097 (26.6)

40,950 (29.9)

High-income

28,464 (39.1)

35,223 (54.8)

63,691 (46.5)

Han Nationality

70,333 (96.7)

62,106 (96.7)

13,2439 (96.7)

Median (IQR)

25.0 (22.8–27.6)

25.3 (23.2–27.4)

25.2 (23.0–27.5)

Underweight (< 18.5 kg/m2

1050 (1.4)

802 (1.2)

1852 (1.4)

BMIa

Normal (18.5 - < 24.0)

25,864 (35.6)

21,237 (33.1)

47,101 (34.4)

Overweight (24.0 - < 28)

30,690 (42.2)

29,316 (45.6)

60,006 (43.8)

Obesity (≥28.0)

15,108 (20.8)

12,879 (20.1)

27,987 (20.4)

Median (IQR)

86.0 (80.0–93.0)

86.0 (80.0–93.0)

86.0 (80.0–93.0)

Normal < 90/85 cm (M/W)

31,077 (42.7)

25,676 (40.9)

56,753 (41.9)

Waist circumference†

Central obese ≥90/85 cm (M/W)

41,621 (57.3)

37,083 (59.1)

78,704 (58.1)

Diabetes Mellitus

20,529 (28.2)

21,008 (32.7)

41,537 (30.3)

Hypertension

46,155 (63.5)

39,280 (61.2)

85,435 (62.4)

Drinking (Current)

14,082 (19.4)

12,084 (18.8)

26,166 (19.1)

Smoking (Current)

25,677 (35.3)

19,174 (29.9)

44,851 (32.8)

Physical inactivity

23,455 (32.3)

28,599 (44.5)

52,054 (38.0)
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Table 1 Demographic, metabolic and lifestyle characteristics of rural and urban 40–100 year-old Chinese adults (Continued)
Rural (N = 72,712)

Urban (N = 64,233)

Total (N = 13,6945)

No. (%)

No. (%)

No. (%)

TC mmol/l

4.92 (4.22–5.64)

4.88 (4.23–5.58)

4.90 (4.23–5.61)

HDL-C mmol/l

1.35 (1.10–1.65)

1.28 (1.08–1.55)

1.31 (1.09–1.60)

LDL-C mmol/l

2.85 (2.20–3.42)

2.85 (2.24–3.40)

2.85 (2.21–3.41)

Triglycerides mmol/l

1.50 (1.04–2.16)

1.51 (1.09–2.15)

1.50 (1.06–2.15)

3.51 (2.80–4.24)

3.53 (2.88–4.22)

3.52 (2.84–4.23)

Lipid variables: Median (IQR)

‡

Non-HDL-C mmol/l

Data are N (%) or median (IQR), interquartile range. Waist circumference† has missing values of 1489 (1.1%);
Non-HDL-C‡ has missing values of 76 (0.1%). TC total cholesterol; HDL-C high-density lipoprotein; LDL-C low-density lipoprotein: triglycerides; M/W Men/ Women;
BMIa calculated as weight in kilograms divided by height in meters squared: b,c Two different geographic zones of china

observed in obese and diabetic participants. Raised TG
was 23% in smokers and 26% in drinkers.
In the multivariable logistic regression analyses, subjects aged 50 years and above were more likely to have
raised TC, raised LDL-C and raised non- HDL-C, but
less likely to develop low HDL-C and raised TG than
those aged 40–49 years. Women were at a higher risk of
raised TC, raised LDL-C and raised non-HDL-C, but at
a lower risk of low HDL-C than men. Urban residence,

Han ethnicity and history of stroke showed significant
associations with lipid abnormalities. History of dyslipidemia was a positively associated factor for dyslipidemia
components except raised TG. Respondents with a history of CHD were unlikely to get dyslipidemia except
raised TC. Overweight, obesity, central obesity and diabetes were associated with a high risk of all components
of dyslipidemia. Geographically, people who stayed in
the stroke belt and the northern parts of China had

Table 2 The serum lipid concentrations of the study population by area of residence
Overall

Rural

Urban

P (95% CI)

P (95% CI)

P (95% CI)

Desirable <5.2 (< 200)

60.7 (60.4–60.9)

59.5 (59.2–59.9)

61.9 (61.5–62.3)

Borderline high ≥5.2 (200) and - < 6.2 (240)

28 .0 (27.8–28.2)

28.7 (28.3–29.0)

27.2 (26.9–27.6)

High ≥6.22 (240)

11.3 (11.2–11.5)

11.8 (11.6–12.0)

10.9 (10.6–11.1)

Desirable < 2.6 (100)

39.1 (38.8–38.3)

39.2 (38.9–39.6)

38.9 (38.5–39.2)

Near optimal ≥2.6 (100) and < 3.4 (130)

34.5 (34.2–34.7)

34 (33.6–34.3)

35 (34.6–35.3)

Borderline high ≥3.4 (130) and 4.1(160)

18.4 (18.2–18.6)

18.4 18.1–18.7)

18.4 18.1–18.7)

High ≥4.1 (160)

8.1 (7.9–8.2)

8.3 (8.1–8.5)

7.8 (7.6–8.0)

Low < 1.0 (< 40)

19.9 (19.7–20.1)

19.2 (18.9–19.5)

20.8 (20.5–21.1)

Desirable ≥1.0 (40) and 1.6 (60)

51.6 (51.3–51.9)

48.9 48.6–49.3)

54.7 (54.3–55.0)

High ≥1.6(≥60)

28.5 (28.2–28.7)

31.9 (31.6–32.2)

24.6 (24.2–24.9)

LIPID VARIABLES
Total cholesterol mmol/L (mg/dL)

LDL-C* mmol/L (mg/dL)

HDL-C* mmol/L (mg/dL)

Triglycerides, mmol/L (mg/dL)
Desirable < 1.7 (< 150)

58.5 (58.2–58.7)

58.4 (58.1–58.8)

58.5 (58.2–58.9)

Borderline high 1.7 (150) and 2.3 (200)

19.1 (18.9–19.3)

19.2 (18.9–19.5)

19 (18.7–19.3)

High ≥2.3 (≥200)

22.4 (22.2–22.6)

22.4 (22.1–22.7)

22.5 (22. 2–22.8)

Desirable < 4.1 (< 160)

70.9 (70.6–71.1)

70.8 (70.4–71.1)

71 (70.6–71.3)

Borderline ≥4.1 (160) and < 4.9 (190)

18.7 (18.5–18.9)

18.3 (18.1–18.6)

19 (18.7–19.3)

High ≥4.9 (190)

10.5 (10.3–10.6)

10.9 (10.7–11.1)

10 (9.8–10.2)

Non- HDL-C* mmo/l (mg/dl)

*LDL-C low-density lipoprotein; *HDL-C high-density lipoprotein. †Non HDL-C has missing values of 76
(0.1%); P percentage; CI Confidence interval
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Fig. 1 Prevalence of dyslipidemia according to area of residence among the study population

significant associations with raised TC, low HDL-C,
raised LDL-C and raised TG. Hypertensives and current
alcohol users were more likely to get all types of dyslipidemias except low HDL-C. Participants who engaged in
regular physical activities were at a lesser risk of adverse
blood lipid levels (Table 4).

all resident in China, having been selected randomly
from rural and urban areas of all provinces and municipalities of the country except Tibet. Therefore, this study
offers a representative feature applicable to the Chinese
population.
Main findings

Discussion
Our study used a large population of Chinese adults of
40 years or above, who were enrolled in the 2014
CNSSPP. To our knowledge, this is the first study to nationally compare rural and urban prevalence of dyslipidemia and risk factors among middle-aged and older
Chinese adults (≥40 years). The study participants were

The following were the main findings of this study: first,
the overall adjusted prevalence of dyslipidemia was 43%.
The overall dyslipidemia prevalence in rural and urban
areas were comparable, 43.2 and 43.3%, respectively.
Further, our data suggested that the adjusted prevalence
of low HDL-C was higher in urban than in rural residents. Raised LDL-C, raised TC and raised non-HDL-C

Fig. 2 Prevalence of dyslipidemia by different age groups and sex among the study population
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Fig. 3 Prevalence of dyslipidemia according to sex in rural and urban residences among the study population

levels were higher among rural than among urban residents and the difference was more pronounced in raised
TC. Additionally, we identified overweight, obesity, central obesity, and diabetes as positive associated factors of
dyslipidemias. Age groups, urban residence, Han nationality, current alcohol use, and hypertension showed
significant associations with all dyslipidemias types.
Regular physical activity was negatively associated with
dyslipidemia.
Table 3 Prevalence of dyslipidemia by some cardiovascular risk
factors
Risk factors (N)

TC

HDL-C

LDL-C

TG

Non-HDL-C

(%)

(%)

(%)

(%)

(%)

Male (70,563)

14

24

7

23

9

Female (66,383)

9

16

9

22

12

Normal/underweight (48,953)

10

17

7

16

9

Overweight (60,006)

11

21

8

24

11

Obese (27,986)

13

23

10

30

13

Diabetic (95,407)

13

22

9

26

12

Non- diabetic (41,537)

11

19

8

21

10

Hypertensive (85,435)

13

20

9

25

12

Non-hypertensive (51,510)

10

20

7

19

9

Smoker (44,851)

10

23

8

23

9

Non-Smoker (92,095)

12

19

8

22

11

Drinker (26,166)

11

20

8

26

10

Non-drinker (11,0778)

11

20

8

22

11

Physical activity (52,054)

12

20

9

24

11

Physical inactivity (84,891)

11

20

8

22

10

LDL-C raised low-density lipoprotein; HDL-C low high-density lipoprotein; TG
raised triglycerides TC raised total cholesterol; N total number of subjects

Comparison of findings with other studies
Prevalence of dyslipidemia

In the past few decades, CVD has increased in low- and
middle-income countries with a decline in several developed countries [26]. In view of this, it is crucial to
understand the role of major risk factors of this emerging epidemic, dyslipidemia being one of them, and their
effective control. The overall dyslipidemia prevalence
(43%) found in this study was higher than the 34.0% reported by a recent study [27], and 41.9% by a study of
dyslipidemia prevalence among Chinese adults in 2014
[28]. Likewise, the overall prevalence of dyslipidemia in
rural and urban areas of our study (as indicated earlier),
was higher than the rural (17.7%) and urban (21%)
prevalence reported among Chinese adults in 2005 [29].
The low HDL-C level observed among urban residents
was consistent with earlier reports [30–32], and showed
the unhealthy HDL-C lipid profile status among urban
adults which could put them at risk of coronary artery
disease (CAD) [11]. The high prevalence of raised TC,
raised non-HDL-C and raised LDL-C levels among rural
residents was similar to findings from a previous study
among adults in rural areas of Northern China [33]. The
reasons for the above results could be attributed to the
following: first, the dramatic epidemiologic transition
(i.e. the shift from infectious to chronic diseases) experienced by China in recent years. This shift was driven by
increases in the prevalence of many known risk factors
for chronic diseases such as unhealthy lifestyles (e.g.
decreased physical activity, excessive smoking, excessive
alcohol use, and westernized diet) [34, 35]. Second, is
the impact of China’s rapid economic growth and
urbanization. A study has noted that poor early life
conditions could increase the risk of obesity in a
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Fig. 4 a-e: Age- and sex-specific prevalence of dyslipidemia components in the study

subsequently more socio-economically developed environment [36]. Again, to some extent, urbanized rural villages might share the environmental risk factors of cities
(e.g. water and air pollutions), but may not enjoyed the
advantage (e.g. available recreational resources, access to
convenient health care services). And our study found
that subjects from rural areas had higher values for
current drinking, current smoking and hypertension.
This result was consistent with a previous report which
indicated that current smoking and drinking increase
the risk of dyslipidemia [37]. A study in Central India reported a higher dyslipidemia prevalence in rural (74.5%)
and urban (68.8%) areas [38]. The differences in prevalence between our study and the Indian study could be
attributed to the disparities in lifestyles, genetics and
socio-economic status, as well as the diagnostic criteria
used in these studies. The situation has important policy
implications for health service planners and policy

makers in China to design appropriate health programs
and strategies to control this disease.
The prevalence of raised TG as found in our study
was high and similar in both living areas- rural (22.4%)
and urban (22.5%). This suggests that the included populations could be prone to CHD [12]. Elevated TG levels
have been identified as a residual CV risk, even in persons on LDL-C lowering therapies like statins [39, 40].
As a result, the adoption and promotion of healthy lifestyle among adults in addition to the usage of TGlowering agents could help reduce this abnormality and
residual risks [41].
Risk factors associated with dyslipidemia

Age, according to the ATP III protocol, is a known nonmodifiable risk factor for CHD, and CHD risk increases
sharply with advancing age [42]. In our study, adults of
all age groups had positive associations with raised TC,
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Table 4 The associations of socio-demographic characteristics and cardiovascular disease risk factors with dyslipidemia in Chinese
adults ≥40 years
TC

HDL-C

LDL-C

TG

Non-HDL-C

40–49

1.00

1.00

1.00

1.00

1.00

50–59

1.48 (1.41–1.55)

0.86 (0.83–0.89)

1.42 (1.35–1.50)

0.95 (0.92–0.98)

1.41 (1.34–1.47)

60–69

1.70 (1.61–1.80)

0.85 (0.81 - -0.88)

1.53 (1.44–1.63)

0.84 (0.81–0.87)

1.56 (1.47–1.64)

70 and above

1.64 (1.55–1.75)

0.77 (0.74–0.81)

1.49 (1.39–1.60)

0.68 (0.65–0.71)

1.49 (1.40–1.59)

Rural

1.00

1.00

1.00

1.00

1.00

Urban

0.90 90.87–0.93)

1.04 (1.01–1.07)C

0.91 (0.87–0.94)

1.06 (1.04–1.09)

0.90 (0.87–0.94)

1.00

1.00

1.00

1.00

Age (years)

Residence

Sex
Men
Women

1.83 (1.75–1.91)

0.62 (0.60–0.64)

1.00
NS

1.55 (1.47–1.63)

1.02 (1.00 - 1.06)

1.52 (1.45–1.59)

Socio- economic regions
Low-income

1.00

1.00

1.00

1.00

1.00

Middle-income

1.10 (1.05–1.16)

0.85 (0.82–0.88)

0.88 (0.83–0.93)

1.35 (1.30–1.40)

1.02 (0.98–1.08)NS

High-income

1.06 (1.01–1.11)C

0.82 (0.79–0.85)

0.90 (0.85–0.95)

0.92 (0.88–0.95)

0.97 (0.93–1.03)NS

Han nationality

1.76 (1.56–1.99)

0.71 (0.67–0.76)

0.88 (0.79–0.98)C

1.14 (1.06–1.22)C

1.50 (1.34–1.68)

Others

1.00

1.00

1.00

1.00

1.00

0.93 (0.78–1.09) NS

0.87 (0.76–0.99)C

0.87 (0.71–1.06)NS

0.65 (0.56–0.75)

0.84 (0.71–1.01)NS

Ethnicities

BMI
Underweight
Normal weight

1.00

1.00

1.00

1.00

1.00

Overweight

1.11 (1.07–1.16)

1.15 (1.12–1.19)

1.18 (1.12–1.24)

1.41 (1.37–1.46)

1.21 (1.16–1.26)

Obesity

1.27 (1.20–1.33)

1.27 (1.22–1.33)

1.34 (1.26–1.42)

1.79 (1.72–1.87)

1.41 (1.33–1.48)

Yes

1.05 (1.01–1.09)

1.24 (1,20–1 28)

1.13 (1.08–1.18)

1.25 (1.22–1.29)

1.08 (1.04–1.13)

No

1.00

1.00

1.00

1.00

1.00

Yes

1.00 (0.94–1.06)NS

0.63 (0.60–0.66)

0.89 (0.83–0.96)C

0.77 (0,74–0.80)

0.91 (0.85–0.96)

No

1.00

1.00

1.00

1.00

1.00

Yes

1.06 (1.02–1.10)

1.09 (1.06–1.13)

1.18 (1.13–1.23)

0.98 (0.96–1.01)NS

1.09 (1.05–1.13)

No

1.00

1.00

1.00

1.00

1.00

Yes

0.92 (0.88–0.96)

0.93 (0.90–0.96)

1.00 (0.95–1.05)

0.73 (0.70–0.75)

0.91 (0.87–0.95)

No

1.00

1.00

1.00

1.00

1.00

Yes

1.00 (0.95–1.05)

1.12 (1.07–1.17)

0.92 (0.86–0.97)C

1.44 (1.38–1.50)

0.99 (0.94–1.05)NS

No

1.00

1.00

1.00

1.00

1.00

North

1.12 (1.07–1.17)

0.61(0.59–0.63)

1.13 (1.08–1.19)

0.67 (0.65–0.69)

0.98 (0.94–1.02)NS

South

1.00

1.00

1.00

1.00

1.00

1.14 (1.10–1.19)

1.18 (1.14–1.21)

1.17 (1.12–1.22)

1.25 (1.22–1.29)

1.21 (1.16–1.25)

Central obesity

History of CHD

History of Dyslipidemia

History of Stroke

Stroke Belt

Geographical region

Diabetes Mellitus
Yes

Opoku et al. BMC Public Health

(2019) 19:1500

Page 11 of 15

Table 4 The associations of socio-demographic characteristics and cardiovascular disease risk factors with dyslipidemia in Chinese
adults ≥40 years (Continued)
TC

HDL-C

LDL-C

TG

Non-HDL-C

1.00

1.00

1.00

1.00

1.00

Yes

1.20 (1.15–1.24)

0.95 (0.92–0.97)

1.23 (1.18–1.29)

1.23 (1.19–1.26)

1.20 (1.15–1.24)

No

1.00

1.00

1.00

1.00

1.00

Yes

1.02 (0.97–1.07)NS

1.01 (0.97–1.04) NS

1.21 (1.15–1.28)

0.99 (0.96–1.03)NS

1.06 (1.01–1.12)C

No

1.00

1.00

1.00

1.00

1.00

Yes

1.33 (1.27–1.40)

0.76 (0.73–0.79)

1.15 (1.08–1.22)

1.18 (1.13–1.22)

1.16 (1.10–1.22)

No

1.00

1.00

1.00

1.00

1.00

0.96 (0.92–0.99)C

0.95 (0.92–0.97)

0.94 (0.90–0.98)C

0.89 (0.86–0.91)

0.96 (0.92–0.99)C

1.00

1.00

1.00

1.00

1.00

No
Hypertension

Current smoker

Current drinker

Physical activity
Yes
No

Figures are both locations pooled ORs (95% CIs). 1.00 = reference group
All the presented 0Rs are significant at p < 0.001 except for: Cp < 0.05; NS, not significant (p > 0.05)
CNSSPP database, HDL-C low high-density lipoprotein; LDL-C raised low-density lipoprotein; TG raised triglycerides, TC raised total cholesterol; Non- HDL-C raised
non-high-density lipoprotein

raised LDL-C and raised non- HDL-C, which was partially consistent with a previous study [10]. At any given
level of LDL-C, the risk for CHD is higher in older than
in younger people. Also, TC level increases with ageing,
but remains relatively stable around age 70 [10]. Some
earlier studies have found that TG and other lipoprotein levels could increase as a result of increasing age
[10, 13, 43]. Due to the ongoing demographic transition
in China, the proportion of people of advancing age is
also expected to go up [14]. With increasing age as a
predisposing factor for dyslipidemia, the elderly are at a
greater risk of developing CVD. Therefore, preventive
strategies including regular screening of serum lipids
and initiation of early treatments among older people
should be intensified.
One study proved that at any given age, men are at
greater risk for CHD compared with women. Additionally, the male sex was considered as a non-modifiable
risk factor for CHD by the ATP III guidelines [42]. It
was therefore unsurprising from our results that
women had lower odds of low HDL-C. Nonetheless,
the underlying etiologies for this observed gender disparity regarding the likelihood of developing CHD are
not completely understood. One probable explanation
is the earlier onset of CHD risk factors such as hypertension in men. However, the Framingham Heart
Study noted that absolute risk differences in both sexes
cannot be entirely explained by standard risk factors
[42]. For this reason, further studies are required with
regard to pathophysiological, behavioral, and sociodemographic risk factors that could contribute to this
higher prevalence of low HDL-C observed among men.

However, women demonstrated higher likelihoods for
the following lipid abnormalities in our study: raised
TC, raised non-HDL-C and raised LDL-C. This finding
was comparable to an earlier study which noted that
menopause can affect lipid parameters by increasing
LDL-C, TG and TC levels and decreasing HDL-C level.
Considering the ages of the women in this study, some
of them could be in postmenopausal state. Hence, we
speculate that these differences could be as a result of
the effects of sex hormones [44].
In the present study, we also analyzed the associations
between the individual components of dyslipidemia and
the personal histories of CHD, dyslipidemia and stroke.
We found that personal history of stroke was positively
associated with raised LDL-C. The personal history of
dyslipidemia was associated with higher odds of raised
(TC, LDL-C, non-HDL-C), and low HDL-C. These observed associations support the beneficial health effects
of effective control strategies such as awareness creation
[45], regular medical screening and monitoring of serum
lipids among adults for the prevention and management
of dyslipidemia. Several potential mechanisms might
have contributed to these relationships hence, further investigations would be required to explain the findings.
Participants from the northern zone of China demonstrated significant associations with raised TC and raised
LDL-C. These results indicate that living in the northern
sector of China tend to be more of a risk to some dyslipidemias. The reasons for these associations might be
partly attributable to factors such as cold temperature
and dietary habits [20]. Some parts of the northern territories of China experience the cold temperate monsoon
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climate. This extremely cold weather could lead inhabitants to eat more animal foods as compared to fruits
and vegetables due to shortages. Additionally, this cold
weather can restrain people from doing sufficient outdoor physical activity during periods like the winter season. As a result of the decrease in physical activities,
residents could be at risk of overweight or obesity with
consequent high risk of dyslipidemia. The stroke belt
zone was positively related to raised TC, low HDL-C
and high TG in our study. The INTERSTROKE study
observed that China’s stroke burden can be attributable
to the combined effects of modifiable risk factors including metabolic risk factors such as high TC [46]. Again,
the clustering of CVD risk factors among residents of
northern china could partially explain this finding [47].
Therefore, the need to scale-up awareness creation and
the greater use of lipid-lowering drugs is pertinent.
Previous studies have noted increasing values for BMI
and WC among dyslipidemic subjects [22, 27, 31]. These
findings were confirmed by our study which demonstrated that adults with higher than normal body weight
(i.e., overweight/obesity) and WC (i.e., central obesity)
had higher likelihoods of acquiring all dyslipidemias.
Particularly, some studies have demonstrated that overweight and obesity could be related to low HDL-C and
elevated TG [23, 30], and weight loss improves atherogenic lipid profile [11]. However, a longer-term perspective that focuses on controlling obesity is needed, and
for this reason, considerable resources should be allocated to the promotion of healthy lifestyles to reduce
obesity. Educating adults on lifestyle modification and
encouraging healthy lifelong habits should be a prime
focus.
According to the Framingham Heart Study, over 80%
of subjects with hypertension had at least an additional
disease risk factor. Hypertension and dyslipidemia are
key risk factors of CVD. Studies have found that dyslipidemia can cause endothelial damage which can lead to
loss of physiological vasomotor activity with consequent
elevated systemic blood pressure. Also, the presence of
dyslipidemia has been found to be more frequent in
hypertensive than in normotensive subjects [48].
Other studies have also indicated that raised TC and
hypertension can coexist, and can result in what is
known as dyslipidemic hypertension [49]. Participants
with raised TC, raised LDL-C, raised TG and raised
non-HDL-C were more likely to have hypertension; this
is comparable to other studies [23, 27]. Similarly, not
only did Cetin et al. [43] demonstrate a positive correlation between raised (TC, LDL-C and TG) and hypertension, but they also reported the combined effects of
hypertension and dyslipidemia on the greater likelihood
of cardiovascular events. Consequently, the risk of acquiring CVD owing to dyslipidemia and hypertension
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co-existence could be multiplicative [37]. Appropriate
management of this comorbidity will remain crucial to
minimizing disease complications in the short- and
medium-term.
Subjects with diabetes demonstrated higher odds of all
dyslipidemia components. Diabetes-dyslipidemia comorbidity has been reported in large community-based
surveys [23, 27, 41]. A previous study showed that the
likelihood of cardiovascular events is increased in individuals with type-2 diabetes, and dyslipidemia could be a
contributing factor with often poor results [50]. The above
co-morbidities constitute the important components of
metabolic syndrome (MS). Therefore, enhancing routine
risk assessments and aggressive pharmacological management of dyslipidemia among affected individuals is
imperative.
Our analysis revealed that current alcohol drinkers
were less likely to develop low HDL-C than nondrinkers. The NCEP ATP III guideline had indicated
that small amounts of alcohol could increase HDL-C
levels [23]. HDL-C relates to alcohol linearly, which is
homogeneous within a population and it is hardly
dependent on factors of genetic origin [51]. Current alcohol users showed higher positive association with
raised TC than raised (LDL-C, TG and non-HDL-C)
values. Alcohol use has been found to be independently
associated with raised TG in a working population [49],
as well as its association with the inability to achieve adequate control of hypertriglyceridemia [52].
Our results suggest that participants who engaged in
regular physical activities had lower odds of dyslipidemia. The positive effects of exercises on serum lipids
have been studied extensively. Physical fitness and regular exercises can considerably reduce absolute cardiovascular risk and death rate [8, 53]. Thus, strategies to
improve the adoption and adherence to exercise programs should be emphasized to improve health.
Ultimately, the high prevalence of dyslipidemia with
the associated risk factors seen in this study should serve
as enough incentives for steps to be taken by authorities
for their control. All risk factors that could play major
roles in blood lipid pathology must be targeted.
Strengths

This study is the first to use a nationally representative
sample of middle-aged and older Chinese adults (≥40
years) to compare rural and urban prevalence of dyslipidemia and risk factors based on the 2014 CNSSPP data
with a robust methodology. The geographically large
and diverse coverage makes the survey generalizable for
China. This study demonstrated that identified risk factors of dyslipidemia such as female sex, overweight,
obesity, central obesity and diabetes were comparable to
those found elsewhere. Therefore, interventions such

Opoku et al. BMC Public Health

(2019) 19:1500

awareness creation programs and greater use of lipidlowering drugs [45] used in other countries could be
replicated in China. This study’s results could also be
used as part of China’s rural-urban dyslipidemia epidemiology baseline data. Finally, it brought to the fore
the need to intensify dyslipidemia intervention programs
among Chinese adults.
Limitations

The limitations of this study also warrant discussion.
Firstly, we performed a cross-sectional study using
CNSSPP data to provide a snapshot of rural and urban
dyslipidemia prevalence in China, thus, causal pathways
underlying the reported associations cannot be ascertained. Secondly, information on lipid-lowering therapy
were not used due to missing data, which might lead to
an underestimation of the prevalence, and the associations towards the null value. Thirdly, the likelihood of
lipid lowering drugs usage among some participants
could have contributed to the low prevalence of raised
LDL-C in the study [54]. Fourthly, all study participants
were aged ≥40, therefore the results may not be
generalizable to younger populations. Lastly, information
bias might have been introduced from the questions on
self-reported demographic and lifestyle risk factors such
as smoking.

Conclusions
In summary, our study estimated the overall prevalence
of dyslipidemia among rural and urban adults in China
as 43.2 and 43.3%, respectively. Dyslipidemia was more
common in women in both rural and urban areas. It was
higher in men than in women before age 50, but increased in women than in men after age 59. Low HDL-C
was higher among urban compared to rural residents
with 20.8% vs. 19.2%, respectively. Raised non-HDL-C
was slightly higher in rural versus urban subjects (10.9%
vs. 10.0%). Raised TC and raised LDL-C values were
more prevalent among rural inhabitants. Raised TG was
high and similar in both rural and urban areas (22.4% vs.
22.5%). Overweight, obesity, central obesity and diabetes
were common risk factors for dyslipidemias. Hypertensives and current drinkers were less likely to get low
HDL-C. Therefore, in order to reduce the prevalence of
dyslipidemia, a multifaceted approach with special attention to controlling identified risk factors is crucial.
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